| Followers | 11 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Thursday, June 06, 2024 7:41:26 PM
https://www.youtu be.com/watch?v=OvC-86SN9Ao&ab_channel=VJOncology
australian KOL on IOBT
many things pointing at it becoming the SOC one day...
australian KOL on IOBT
many things pointing at it becoming the SOC one day...
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 10:22:46 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 10:06:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:53:41 PM
- IO Biotech Provides Corporate Update • GlobeNewswire Inc. • 01/30/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 11:05:41 AM
- IO Biotech Announces Exploration of Strategic Alternatives • GlobeNewswire Inc. • 01/21/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 10:18:23 PM
- IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications • GlobeNewswire Inc. • 12/15/2025 09:05:00 PM
- IO Biotech Announces Participation in Upcoming December Investor Conferences • GlobeNewswire Inc. • 11/26/2025 03:46:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:44:15 PM
- Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For • InvestorsHub NewsWire • 11/20/2025 02:00:00 PM
- Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For • GlobeNewswire Inc. • 11/20/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 11:30:19 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:10:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 01:10:14 PM
- IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 11/14/2025 01:05:00 PM
- IO Biotech Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/12/2025 01:30:00 PM
- IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) • GlobeNewswire Inc. • 11/07/2025 02:00:00 PM
- Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology • InvestorsHub NewsWire • 10/27/2025 01:00:00 PM
- Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology • PR Newswire (US) • 10/27/2025 12:30:00 PM
- Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology • PR Newswire (Canada) • 10/27/2025 12:30:00 PM
- IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025 • GlobeNewswire Inc. • 10/20/2025 06:30:00 AM
- Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion • PR Newswire (Canada) • 10/07/2025 01:00:00 PM
